Ask AI
ProCE Banner Activity

Case Challenges in Systemic Mastocytosis: Expert Answers to Your Questions

Clinical Thought

Learn best practices for identifying patients with systemic mastocytosis, including the symptoms and red flags that warrant referral to other specialties, and specific considerations for integrating targeted therapies in personalized treatment plans.

Released: May 06, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Blueprint Medicines, a Sanofi company.

Blueprint Medicines, a Sanofi company

Target Audience

This activity is intended for US-based physicians, including residents and fellows; physician associates; and nurse practitioners practicing in allergy/immunology and dermatology who care for patients with systemic mastocytosis.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the pathogenesis, spectrum of clinical presentation, and differential diagnosis of SM

Disclosure

Primary Author

Benjamin Ungar, MD: consultant/advisor/speaker: AbbVie, Botanix, Bristol Myers Squibb, Ebla Holdco, Galderma, Johnson & Johnson, Leo, Lilly, Nektar, Pfizer, Sanofi, Veradermics, VRG Therapeutics.